Inactive Instrument

Analyst Reco. Rain Oncology Inc.

Equities

RAIN

US75082Q1058

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Citigroup Trims Rain Oncology's Price Target to $1 From 1.50, Keeps Neutral Rating	23-09-18	MT
Mizuho Downgrades Rain Oncology to Neutral From Buy, Adjusts Price Target to $1 From $17	23-06-05	MT
EF Hutton Cuts Rain Oncology's Price Target to $2 From $5, Maintains Hold Rating	23-05-30	MT
Roth MKM Downgrades Rain Oncology to Neutral From Buy, Trims Price Target to $1.20 From $2	23-05-30	MT
Oppenheimer Downgrades Rain Oncology to Perform From Outperform, Removes $16 Price Target	23-05-23	MT
LifeSci Capital Downgrades Rain Oncology to Market Perform From Outperform Rating	23-05-23	MT
SVB Securities Downgrades Rain Oncology to Market Perform From Outperform, Adjusts Price Target to $2 From $11	23-05-23	MT
Citigroup Downgrades Rain Oncology to Neutral From Buy, Cuts Price Target to $1.50 From $24	23-05-23	MT
Piper Sandler Downgrades Rain Oncology to Neutral From Overweight, Cuts Price Target to $1.75 From $15	23-05-23	MT
HC Wainwright Downgrades Rain Oncology to Neutral From Buy	23-05-23	MT
Guggenheim Downgrades Rain Oncology to Neutral From Buy	23-05-22	MT
EF Hutton Downgrades Rain Oncology to Hold From Buy, Cuts Price Target to $5 From $16	23-05-22	MT
JonesTrading Downgrades Rain Therapeutics to Hold From Buy	23-05-22	MT
SVB Securities Initiates Rain Therapeutics at Outperform With $11 Price Target	23-03-21	MT
Mizuho Adjusts Price Target on Rain Therapeutics to $17 From $18, Keeps Buy Rating	23-03-13	MT
HC Wainwright Adjusts Price Target on Rain Therapeutics to $19 From $12, Keeps Buy Rating	23-03-10	MT
Mizuho Starts Rain Oncology at Buy With $18 Price Target	23-01-23	MT
Lifesci Capital Starts Rain Therapeutics at Outperform With $17 Price Target	23-01-06	MT
EF Hutton Initiates Rain Therapeutics at Buy With $16 Price Target	23-01-05	MT
Citigroup Adjusts Price Target on Rain Therapeutics to $29 From $30, Maintains Buy Rating	22-11-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Rain Oncology Inc.

Equities

RAIN

US75082Q1058

Analyst Reco.

Filters